Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| University Hospital Tuebingen | OTHER |
Not provided
Not provided
Not provided
Not provided
The aim of this longitudinal, observational study is to investigate the effects of gender-affirming hormone treatment in FTM (female to male) and MTF (male to female) transgender (TG) people with regard to changes in brain structure and function as well as psychological and behavioral consequences. Methodological problems and missing studies in this area were mentioned several times with an emphasis on the need for longitudinal research.
Transgender (TG) is still a polarizing issue today. The lack of acceptance in society and often even in one's own family, the feeling of a lack of identity and connection with one's own body and the experienced discrimination all lead to a considerable degree of suffering in TG and elevated levels of psychiatric symptoms as well as a reduced quality of life. Many TG people seek hormonal treatment. Physical and psychological consequences of this treatment still need to be revealed.
To this aim, the investigators recruit TG people (MTF and FTM) who intend to seek gender-affirming hormonal treatment. Before treatment, various measures will be taken, including a semi-structured interview to assess psychiatric symptoms, self-ratings, behavioral experiments (to assess male/female face recognition and male/female voice perception), while functional MRI scans are taken to assess respective neural correlates. In addition, resting-state scans as well as anatomic images will be taken.
Six months after having started gender-affirming hormone treatment, participants will be reinvited to undergo the same study protocol.
In between testing sessions, patients will perform several online surveys regarding their psychological well-being.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Patient | Transgender people who seek hormone treatment | ||
| Control participants | volunteers without gender dysphoria |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| changes in anatomical MRI | measurment of anatomical differences between the groups and changes in the TG group throughout the gender-affirming hormone treatment | 7 minutes; assessed before gender affirming hormone therapy starts and 6 months after onset (corresponding time points are chosen for the healthy controls) |
| changes in Resting-state MRI measurements | measurment of resting-state activation differences between the groups and changes in the TG group throughout the gender-affirming hormone treatment | 10 minutes; assessed before gender affirming hormone therapy starts and 6 months after onset |
| changes in Functional MRI measurements | measurment of activation differences during a voice and a face gender-recognition task between the groups and changes in the TG group throughout the gender-affirming hormone treatment | 1 hour; assessed before gender affirming hormone therapy starts and 6 months after onset |
| changes in self-ratings regarding quality of life throughout gender-affirming hormone treatment : WHOQoL-BREF | items regarding different aspects of daily life, 5-point likert scale, changes are measured for TG, CG are used as a control for potential natural changes over time | 1 hour; assessed before gender affirming hormone therapy starts and 6 months after onset |
| changes in self-ratings regarding quality of life throughout gender-affirming hormone treatment: Gender Congruence and Life Satisfaction Scale | items regarding influence of gender congruence on different aspects of daily life, 5-point likert scale; changes are measured for TG, CG are used as a control for potential natural changes over time | 1 hour; assessed before gender affirming hormone therapy starts and 6 months after onset |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Transgender people seeking gender-affirming hormonal treatment who fullfill the inclusion criteria
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Ute Habel, Prof. Dr. | Contact | + 492418080368 | uhabel@ukaachen.de | |
| Birgit Derntl, Prof. Dr. | Contact | + 49 7071 29 85437 | Birgit.Derntl@med.uni-tuebingen.de |
| Name | Affiliation | Role |
|---|---|---|
| Ute Habel, Prof. Dr. | Uniklinkum Aachen | Study Director |
| Birgit Derntl, Prof. Dr. | Uniklinikum Tübingen | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Uniklinik RWTH Aachen | Recruiting | Aachen | 52062 | Germany |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000068116 | Gender Dysphoria |
| ID | Term |
|---|---|
| D020018 | Sexual Dysfunctions, Psychological |
| D001523 | Mental Disorders |
Not provided
Not provided
Not provided
Not provided
Not provided
| changes in self-ratings regarding psychological well-being and psychiatric Symptoms throughout gender-affirming hormone treatment: Brief Symptom Inventory | occurence of different symptoms during the last week, 5-point likert scale; changes are measured for TG, CG are used as a control for potential natural changes over time | 1 hour; assessed before gender affirming hormone therapy starts and 6 months after onset |
| self-ratings regarding psychological well-being and psychiatric: Childhood Trauma Questionnaire | 5-point likert scale | 1 hour; assessed before gender affirming hormone therapy starts |
| changes in self-ratings regarding psychological well-being and psychiatric Symptoms throughout gender-affirming hormone treatment: ENRICHD Social Support Inventory | 5-point likert scale; changes are measured for TG, CG are used as a control for potential natural changes over time | 1 hour; assessed before gender affirming hormone therapy starts and 1, 2, 4 and 6 months after onset |
| changes in self-ratings regarding psychological well-being and psychiatric Symptoms throughout gender-affirming hormone treatment: Positive and negative affect scale | 5-point likert scale; changes are measured for TG, CG are used as a control for potential natural changes over time | 1 hour; assessed before gender affirming hormone therapy starts and 6 months after onset |
| changes in self-ratings regarding psychological well-being and psychiatric Symptoms throughout gender-affirming hormone treatment: Patient Health Questionnaire-9 | items regarding depressive symptoms, 4-point likert scale; changes are measured for TG, CG are used as a control for potential natural changes over time | 1 hour; assessed before gender affirming hormone therapy starts and 1, 2, 4 and 6 months after onset |
| changes in self-ratings regarding personality throughout gender-affirming hormone treatment: Personality Inventory for DSM-5 Brief Form | 4-point likert scale; changes are measured for TG, CG are used as a control for potential natural changes over time | 1 hour; assessed before gender affirming hormone therapy starts and 6 months after onset |
| changes in self-ratings regarding psychological well-being and psychiatric Symptoms throughout gender-affirming hormone treatment: Rosenberg Self-Esteem Scale | 4-point likert scale; changes are measured for TG, CG are used as a control for potential natural changes over time | 1 hour; assessed before gender affirming hormone therapy starts and 6 months after onset |
| changes in self-ratings regarding psychological well-being and psychiatric Symptoms throughout gender-affirming hormone treatment: Stait-Trait-Angst Inventar | 4-point likert scale; changes are measured for TG, CG are used as a control for potential natural changes over timechanges are measured for TG, CG are used as a control for potential natural changes over time | 1 hour; assessed before gender affirming hormone therapy starts and 6 months after onset |
| changes in self-ratings regarding psychological well-being and psychiatric Symptoms throughout gender-affirming hormone treatment: Stress- and Coping Inventar | 7-point likert scale; changes are measured for TG, CG are used as a control for potential natural changes over time | 1 hour; assessed before gender affirming hormone therapy starts and 1, 2, 4 and 6 months after onset |
| changes in self-ratings regarding psychological well-being and psychiatric Symptoms throughout gender-affirming hormone treatment: Strukturiertes Klinisches Interview für DSM 5 | interview conducted by investigator with questions regarding symptoms of different psychiatric disorders; changes are measured for TG, CG are used as a control for potential natural changes over time | 1 hour; assessed before gender affirming hormone therapy starts and 6 months after onset |
| changes in self-ratings regarding sexuality throughout gender-affirming hormone treatment: Multidimensional Sexuality Questionnaires | items regarding sexual relationships, 5-point likert scale; changes are measured for TG, CG are used as a control for potential natural changes over time | 1 hour; assessed before gender affirming hormone therapy starts and 6 months after onset |
| changes in self-ratings regarding gender congruence throughout gender-affirming hormone treatment:Transgender Congruence Scale | 5-point likert scale; changes are measured for TG, CG are used as a control for potential natural changes over time | 1 hour; assessed before gender affirming hormone therapy starts and 6 months after onset |
| changes in self-ratings regarding sex roles throughout gender-affirming hormone treatment: Assessment of Gender-Related Attributes | items regarding typicale male and female personality traits, cognition and interests, 7-point likert scale | 1 hour; assessed before gender affirming hormone therapy starts and 2, 4 and 6 months after onset |
| changes in self-ratings regarding sex roles throughout gender-affirming hormone treatment: Bem Sex Role Inventory | 7-point likert scale; changes are measured for TG, CG are used as a control for potential natural changes over time | 1 hour; assessed before gender affirming hormone therapy starts and 6 months after onset |
| changes in self-ratings regarding percpetion of and satisfaction with own body throughout gender-affirming hormone treatment : Fragebogen zur Beurteilung des eigenen Körpers | each item has to be rated as false or true, resulting in scores for the dimensions self-esteem, insecurities and external appearance; changes are measured for TG, CG are used as a control for potential natural changes over time | 1 hour; assessed before gender affirming hormone therapy starts and 6 months after onset |
| changes in Hormone/protein analyses throughout gender-affirming hormone treatment | (free) testosterone, estradiol, progesterone, BDNF; changes are measured for TG, CG are used as a control for potential natural changes over time | 5 minutes; assessed before gender affirming hormone therapy starts and 6 months after onset |
| Universitätsklinikum Tübingen | Not yet recruiting | Tübingen | 72076 | Germany |
|